Pharmacological therapies used in COVID-19 treament. Bibliographical review
DOI:
https://doi.org/10.5377/rct.v13i25.10410Keywords:
SARS-CoV, MERS-CoV, SARS-CoV-2, pharmacological treatments, clinical trialsAbstract
In late 2019, an outbreak of a disease caused by a new coronavirus known internationally as COVID-19 emerged in China, spreading worldwide and declared a pandemic in March 2020. This virus causes respiratory diseases ranging from very slight to severe symptoms, which may cause the death of the patient. However, the marked increase in the understanding of the virus and the disease has allowed the development of diagnostic tests, current in-vitro trials and clinical trials of drugs, vaccines, and epidemiological control measures. In this article, we carry out a review of the information available in databases such as: Pubmed, MedlinePlus, EMBASE or Scopus, Cochrane Library, LILACS, Spanish Medical Index (IME), among others, until June of this year, to learn more about the pathogen, transmission, symptoms, diagnosis, pathogenesis and focusing on the pharmacological treatments mainly studied worldwide.
Downloads
1757
Downloads
Published
How to Cite
Issue
Section
License
© Revista Ciencia y Tecnología
Authors who publish in this journal accept the following conditions: In accordance with the legislation of copyright, Revista Ciencia y Tecnología, recognizes and respects the moral right of authors, as well as the ownership of the patrimonial right, which will be ceded to the magazine for its diffusion in open access in printed version and in digital format. By being part of multiple indexers, databases and reference systems, the articles published by Revista Ciencia y Tecnología will be visible and will be downloaded from these websites, indicating, in all cases, the authorship of the articles, the date of publication and the number of the journal to which they correspond.
